These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17410119)

  • 21. Optimizing information on drug exposure by collection of package code information in questionnaire surveys.
    Quinzler R; Schmitt SP; Szecsenyi J; Haefeli WE
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1024-30. PubMed ID: 17457950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Provision of information on regulatory authorities' websites.
    Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
    Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of German package inserts.
    Fuchs J; Hippius M; Schaefer M
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):8-13. PubMed ID: 16425965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological information and training for health care services. The Spanish experience and possibilities of Ibero-American cooperation].
    Lobo F
    Rev Sanid Hig Publica (Madr); 1989; 63(1-2):119-25. PubMed ID: 2636784
    [No Abstract]   [Full Text] [Related]  

  • 25. [More information on drug package inserts and counseling replace the warning triangle].
    Beermann B; Liliemark J; Johansson K
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1918, 1921. PubMed ID: 16044776
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical pharmacology in primary care: a good mix?
    Rodríguez-Moreno C; Campoamor F; Martín MV; Muro V
    Therapie; 1996; 51(4):378-81. PubMed ID: 8953812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Family medicine, epidemiological drug research and social pharmacology].
    Alloza JL
    Med Clin (Barc); 1984 Jan; 82(3):124-9. PubMed ID: 6748807
    [No Abstract]   [Full Text] [Related]  

  • 28. The FDA announces new prescription drug information format.
    FDA Consum; 2006; 40(2):25-7. PubMed ID: 16671197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [More than 1 out of 100 will have myocardial infarction and stroke because of enalapril--effect of drug package inserts?].
    Sandström H
    Lakartidningen; 2006 Feb 22-28; 103(8):564, 567; discussion 567. PubMed ID: 16570783
    [No Abstract]   [Full Text] [Related]  

  • 31. Inconsistencies and misleading information in officially approved prescribing information from three major drug markets.
    Pfistermeister B; Saß A; Criegee-Rieck M; Bürkle T; Fromm MF; Maas R
    Clin Pharmacol Ther; 2014 Nov; 96(5):616-24. PubMed ID: 25062063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A 30-year history of the change in package insert for Japanese pharmaceutical medicines].
    Sasaki K; Kondo T
    Yakushigaku Zasshi; 2004; 39(2):276-85. PubMed ID: 16025649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overpromotion of drugs in international product package inserts.
    Saxton C
    Trop Doct; 1983 Oct; 13(4):168-70. PubMed ID: 6649040
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacy alternative futures.
    Smith WE
    Pharm Pract Manag Q; 1998 Jul; 18(2):37-47. PubMed ID: 10185238
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug package inserts and the adequacy of patient's drug information].
    da Silva T; Dal-Pizzol F; Bello CM; Mengue SS; Schenkel EP
    Rev Saude Publica; 2000 Apr; 34(2):184-9. PubMed ID: 10881155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia.
    Gebran N; Al Haidari K
    Ann Saudi Med; 2006; 26(3):192-9. PubMed ID: 16861873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electronic prescribing reduced prescribing errors in a pediatric renal outpatient clinic.
    Jani YH; Ghaleb MA; Marks SD; Cope J; Barber N; Wong IC
    J Pediatr; 2008 Feb; 152(2):214-8. PubMed ID: 18206691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.